Hartford Investment Management Co. lifted its position in CVS Health Corp (NYSE:CVS) by 0.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 165,480 shares of the pharmacy operator’s stock after purchasing an additional 844 shares during the period. Hartford Investment Management Co.’s holdings in CVS Health were worth $9,017,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Bay Harbor Wealth Management LLC raised its position in CVS Health by 1,871.4% during the first quarter. Bay Harbor Wealth Management LLC now owns 552 shares of the pharmacy operator’s stock worth $30,000 after acquiring an additional 524 shares during the period. Centaurus Financial Inc. raised its position in CVS Health by 570.8% during the first quarter. Centaurus Financial Inc. now owns 1,630 shares of the pharmacy operator’s stock worth $30,000 after acquiring an additional 1,387 shares during the period. Manchester Financial Inc. acquired a new position in CVS Health during the second quarter worth $31,000. C J Advisory Inc acquired a new position in CVS Health during the first quarter worth $33,000. Finally, Murphy Pohlad Asset Management LLC acquired a new position in CVS Health during the fourth quarter worth $39,000. Hedge funds and other institutional investors own 77.33% of the company’s stock.
CVS Health stock opened at $55.33 on Monday. CVS Health Corp has a 52-week low of $51.72 and a 52-week high of $82.15. The stock has a market capitalization of $72.37 billion, a price-to-earnings ratio of 7.81, a price-to-earnings-growth ratio of 1.25 and a beta of 0.90. The business’s fifty day simple moving average is $55.36. The company has a debt-to-equity ratio of 1.45, a current ratio of 0.95 and a quick ratio of 0.64.
A number of equities analysts have weighed in on the stock. Mizuho set a $71.00 price objective on shares of CVS Health and gave the stock a “buy” rating in a research report on Wednesday, June 5th. Morgan Stanley reduced their price objective on shares of CVS Health from $92.00 to $74.00 and set an “overweight” rating for the company in a research report on Monday, April 29th. BMO Capital Markets set a $63.00 price objective on shares of CVS Health and gave the stock a “hold” rating in a research report on Friday, May 3rd. Standpoint Research upgraded shares of CVS Health from a “hold” rating to a “buy” rating in a research report on Wednesday, June 5th. Finally, ValuEngine cut shares of CVS Health from a “sell” rating to a “strong sell” rating in a research report on Tuesday, July 2nd. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating, sixteen have given a buy rating and one has issued a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $76.48.
CVS Health Company Profile
CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.
Further Reading: Why do companies pay special dividends?
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.